Targeted high performance liquid chromatography-mass spectrometry (HPLC–MS) of MDA-MB-231 tumor samples metabolomics revealed a distinct metabolite profile upon ALDH1A3 expression. The gene discussed is ALDH1A3; the disease is neoplasm.